Two studies highlight orexin’s insulin-mimetic and vasculoprotective actions in peripheral metabolic tissues, revealing its capacity to enhance glucose disposal in adipocytes and shield endothelial cells from hyperglycemia-induced damage effects that extend orexin’s regulatory reach beyond the central nervous system and pancreas. The gene discussed is HCRT; the disease is Hyperglycemia.